Intra-immusg Pte Ltd

This study tests an experimental drug called PRL3-zumab in 60 adults with advanced solid tumors that have not responded to standard treatments. The drug is given by IV every two weeks to see if it can slow tumor growth or shrink tumors. The main goals are to measure how long pati…

This study tests a drug called PRL3-zumab in 51 adults with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the drug can slow tumor growth or shrink tumors. Participants must have had 1 to 3 prior treatments. This is not a cure, but a…